Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Dihexa for Sale > Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - large image1
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image1
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image2
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image3
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image4
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image5
Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery buy - image6

Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery

180 Inquiries

Unit Price:

$20/UNIT FOB

Get Latest Price
CAS No.:

1401708-83-5

Grade:

Top Grade

Content:

99%

Port:

Tianjin

Brand:

Tengchu

Packaging:

10mg*10/box

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

ghk-cu,Semaglutide,tirzepatide,Retatrutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Linkman: Yara
    WhatsApp: +852 6011 9564
    Email : tengchu02@zhuanjinbio.com


    Dihexa (PNB-0408), an oligopeptide reagent, is an angiotensin IV analog with oral activity and permeability of the blood-brain barrier. Dihexa binds hepatocyte growth factor (HGF) with high affinity with a Kd value of 65 pM and enhances its activity against receptor c-Met. Dihexa showed excellent antipsychotic activity and improved cognitive function in animal models. Dihexa has the potential to study Alzheimer's.


    Items Specifications
    MOQ 10 vials
    Delivery Sent out within 12 hours after payment confirmed
    CAS 1401708-83-5
    Appearance Powder
    Molecular Formula C27H44N4O5
    Molecular Weight 504.662
    Purtity 99%
    Packing 10mg*10/box
    Storage Preserve in tight, light-resistant containers in a cool place
    Custom synthesis Available
    payment Bank Transfer, Money Gram and Bitcoin

    Shop Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery-Detailed Image 1

    Shop Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery-Detailed Image 2

    FAQ

    Q1: May I get one sample before placing order?
    Re: Yes, Sample are available. For normal products, samples are for free and you just need to bear the freight; For those high value products, you just need to freight and certain product cost. When we both cooperate for some times or when you are our VIP customer, free sample will be offered when you need.

    Q2: Which payment is available for your company?
    Re: T/T,Bitcoin etc. You can choose the one which is convenient for you.

    Q3: How and when can I get my goods after payment?
    Re: For small quantity products, they will be delivered to you by international courier(DHL, FedEx, TNT etc.) or by air. Usually it will cost 3-10days that you can get the goods after delivery.For large quantity products, shipping by see is worthwhile.It will cost 15 to 30 days to come to your destination port, which depends on where the port is.

    Q4: Is there any possible to use my appointed label or package?
    Re: Yes. If needed, we'd like to use label or package according to your requirement.

    Q5: How can you guarantee the goods you offer is qualified?
    Re: We always believe honesty and responsibility are basis of one company, so whatever products we provide for you all are qualified. We will have goods tested and provide COA before delivery for sure.


    Delivery

    Shop Dihexa Peptide PNB-0408 cas 1401708-83-5 Factory price high quality safe delivery-Detailed Image 3

    ECHEMI Editorial Reference

    Dihexa is a synthetic peptide-based compound and angiotensin IV analog. As a research and pharmaceutical raw material, Dihexa is characterized by its defined molecular structure and peptide properties. It is primarily used for research, analytical testing, compound evaluation, and pharmaceutical development.

    Basic Info
    Product Name:

    Dihexa

    Other Name:

    L-Isoleucinamide,N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide;Dihexa;N-Hexanoic-Tyr-Ile-(6)aminohexanoic amide

    CAS No.:

    1401708-83-5

    Molecular Formula:

    C27H44N4O5

    InChIKeys:

    InChIKey=XEUVNVNAVKZSPT-JTJYXVOQSA-N

    Molecular Weight:

    504.7

    Exact Mass:

    504.66

    Characteristics
    Density:

    1.111±0.06 g/cm3(Predicted)

    Boiling Point:

    866.2±65.0 °C(Predicted)

    Research
    Class:

    Angiotensin IV-derived oligopeptide / HGF-c-Met potentiator

    Status:

    Research compound — Not FDA approved

    Mechanism:

    A synthetic, orally active, blood-brain-barrier-permeable oligopeptide (Hexanoyl-Tyr-Ile-Ahx-NH₂) derived from angiotensin IV. Dihexa binds hepatocyte growth factor (HGF) with high affinity (Kd = 65 pM) and allosterically potentiates HGF activity at its receptor c-Met, promoting dendritic spinogenesis and synaptogenesis. In preclinical models it was reported to be seven orders of magnitude more potent than BDNF at promoting synapse formation. Note: the foundational 2014 paper (McCoy AT, et al. Neurobiol Learn Mem. 2014) was retracted in 2025.

    EC50 (HGF Binding KD):

    65 pM

    Activity note:

    Dihexa is an HGF potentiator, not a direct receptor agonist. It does not activate c-Met alone but markedly augments HGF-induced c-Met activation at low nanomolar HGF concentrations. Functional synaptogenic activity was reported at 10⁻¹°–10⁻⁻ M (original data now subject to retraction).

    Source:

    Original report: McCoy AT, et al. Neurobiol Learn Mem. 2014;115:112-120 (retracted 2025). Benoist CC, et al. J Pharmacol Exp Ther. 2014;351(3):628-637.

    Clinical Development:

    NCT04488419

    References
    PubChem:

    PubChem

    UNII:

    9WYX65A5C2

    Disclaimer:

    Dihexa is NOT FDA-approved or EMA-approved as a medicine. It is a research compound only. The foundational 2014 paper describing its synaptogenic potency was retracted in 2025. Its phosphate prodrug fosgonimeton failed a Phase 2/3 Alzheimer’s trial (LIFT-AD, 2024). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    ghk-cu,Semaglutide,tirzepatide,Retatrutide

    Location:

    Room 68-5-501, Lianqiang Residential Area, No. 371 Union Road, Union Street, Xinhua District, Shijiazhuang City, Hebei Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2022

  • Inquiry History
    180 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Dihexa

    1 KG Oct 26, 2026
    Thailand

    Dihexa

    1 G Oct 23, 2026
    Australia

    Dihexa

    30 G Oct 19, 2026
    Australia

    Dihexa

    2 G Oct 19, 2026
    United States

    Dihexa

    100 PCS Oct 15, 2026
    United States

    Multi-Product Research Chemical Bulk Sourcing Inquiry

    2.6 KG Oct 8, 2026
    Philippines

    Dihexa

    1 KG Oct 2, 2026
    United States

    dihexa

    10 MG Sep 28, 2026
    Australia

    Dihexa

    1 MT Sep 18, 2026
    United States

    Dihexa

    10 G Sep 9, 2026
    Hungary

    Dihexa

    1 G Sep 7, 2026
    India

    Dihexa

    10 MG Sep 4, 2026
    Spain

    Dihexa

    100 MG Aug 30, 2026
    Spain

    Dihexa

    50 MG Aug 28, 2026
    United Arab Emirates

    Diheza

    1 G Aug 28, 2026
    Norway

    Dihexa

    1 G Aug 26, 2026
    Canada

    Dihexa lyophilized 1401708-83-5

    1  Aug 23, 2026
    Canada

    SHLP2 ; PE-22-28; Dihexa ; TAK-653 ; lyophilized

    10 PCS Aug 23, 2026
    United States

    Dihexa

    1 G Aug 22, 2026
    United States

    Dihexa

    500 G Aug 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.